Trinity Biotech plc announced that Mr. John Gillard, Group Chief Financial Officer, has informed the Board of Directors of the Company of his intention to resign in order assume a senior finance role in an organisation outside the life sciences sector. Mr. Gillard is expected to leave Trinity Biotech in April 2022 and a process to appoint his successor will now commence.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.84 USD | +0.55% | +1.92% | -14.22% |
1st Jan change | Capi. | |
---|---|---|
-14.22% | 17.28M | |
+0.89% | 12.59B | |
-10.29% | 7.42B | |
+1.78% | 5.35B | |
-1.16% | 4.51B | |
+5.77% | 4.47B | |
-50.81% | 3.21B | |
+12.21% | 2.71B | |
-16.13% | 1.96B | |
-11.50% | 1.73B |
- Stock Market
- Equities
- TRIB Stock
- News Trinity Biotech plc
- Trinity Biotech plc Announces John Gillard, Group Chief Financial Officer Intention to Resign